Literature DB >> 1515796

Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine.

C Chrysanthopoulos1, N Kounis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515796      PMCID: PMC1881805          DOI: 10.1136/bmj.304.6836.1225

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy.

Authors:  G E Marais; K K Larson
Journal:  Ann Intern Med       Date:  1990-02-01       Impact factor: 25.391

2.  Plasma mevalonate response in lovastatin-related myopathy.

Authors:  V M Maher; A Pappu; D R Illingworth; G R Thompson
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

3.  Lovastatin, isoprenes, and myopathy.

Authors:  P A Walravens; C Greene; F E Frerman
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

4.  Lovastatin-induced acute rhabdomyolysis.

Authors:  A D Kogan; S Orenstein
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

  4 in total
  1 in total

Review 1.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.